BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18053120)

  • 1. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.
    Cuatrecasas G; Riudavets C; Güell MA; Nadal A
    BMC Musculoskelet Disord; 2007 Nov; 8():119. PubMed ID: 18053120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia.
    Cuatrecasas G; Alegre C; Fernandez-Solà J; Gonzalez MJ; Garcia-Fructuoso F; Poca-Dias V; Nadal A; Cuatrecasas G; Navarro F; Mera A; Lage M; Peinó R; Casanueva F; Liñan C; Sesmilo G; Coves MJ; Izquierdo JP; Alvarez I; Granados E; Puig-Domingo M
    Pain; 2012 Jul; 153(7):1382-1389. PubMed ID: 22465047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.
    Bennett RM; Clark SC; Walczyk J
    Am J Med; 1998 Mar; 104(3):227-31. PubMed ID: 9552084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome.
    Koca TT; Berk E; Seyithanoğlu M; Koçyiğit BF; Demirel A
    Acta Neurol Belg; 2020 Jun; 120(3):595-599. PubMed ID: 30547374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise.
    Jones KD; Deodhar AA; Burckhardt CS; Perrin NA; Hanson GC; Bennett RM
    J Rheumatol; 2007 May; 34(5):1103-11. PubMed ID: 17407215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia.
    Jones KD; Burckhardt CS; Deodhar AA; Perrin NA; Hanson GC; Bennett RM
    Arthritis Rheum; 2008 Feb; 58(2):612-22. PubMed ID: 18240245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome.
    Tander B; Atmaca A; Aliyazicioglu Y; Canturk F
    Joint Bone Spine; 2007 Oct; 74(5):477-81. PubMed ID: 17689128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes.
    Cuatrecasas G; Gonzalez MJ; Alegre C; Sesmilo G; Fernandez-Solà J; Casanueva FF; Garcia-Fructuoso F; Poca-Dias V; Izquierdo JP; Puig-Domingo M
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4331-7. PubMed ID: 20631018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyalgic syndromes: could growth hormone therapy be beneficial?
    Cuatrecasas G
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():529-33. PubMed ID: 19550388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
    Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
    JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin?
    Bjersing JL; Erlandsson M; Bokarewa MI; Mannerkorpi K
    Arthritis Res Ther; 2013 Feb; 15(1):R34. PubMed ID: 23446104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
    Hatton J; Kryscio R; Ryan M; Ott L; Young B
    J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
    Cuatrecasas G; Alegre C; Casanueva FF
    Pituitary; 2014 Jun; 17(3):277-83. PubMed ID: 23568565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P; Rogol AD; Howard CP; Bright GM; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study.
    Giustina A; Mazziotti G; Cannavò S; Castello R; Arnaldi G; Bugari G; Cozzi R; Ferone D; Formenti AM; Gatti E; Grottoli S; Maffei P; Maffezzoni F; Montini M; Terzolo M; Ghigo E
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2454-2464. PubMed ID: 28419317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
    Yuen KC; Bennett RM; Hryciw CA; Cook MB; Rhoads SA; Cook DM
    Growth Horm IGF Res; 2007 Feb; 17(1):82-8. PubMed ID: 17289417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.
    Oscarsson J; Johannsson G; Johansson JO; Lundberg PA; Lindstedt G; Bengtsson BA
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):63-8. PubMed ID: 9059559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.